-
Uncategorized6 months ago
Merck joins forces with Infinimmune to find therapeutic antibodies
Merck is tasking a 10-person biotech to hunt for new human antibody candidates. The drug giant will ship up to $838 million to the startup, called...
-
Uncategorized6 months agoMerck strikes deal with antibody discovery startup
In an R&D collaboration worth as much as $838 million, Merck will lean on Infinimmune to discover immune cell-directed antibodies for multiple targets. Read More
-
Uncategorized6 months agoDDW Highlights: 31 March 2026
The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates the key stories of the previous week to keep...
-
Uncategorized6 months ago
Biogen to buy Apellis for $5.6B
Biogen has made a $5.6 billion deal to acquire Apellis Pharmaceuticals, the companies announced Tuesday. The deal will allow Biogen to get hold of the kidney...
-
Uncategorized6 months ago
Eli Lilly to buy Centessa for $6.3B to get sleep disorder drug
Eli Lilly to buy Centessa for $6.3B to get sleep disorder drug
-
Uncategorized6 months agoBiotech IPOs stayed at slow pace, but grew larger in the first quarter of 2026
The six companies that have priced initial public offerings so far banked a median of $287.5 million, a figure far surpassing what’s been observed over a...
-
Uncategorized6 months agoSTAT+: HSA companies struck it big in Trump’s tax bill. They’re lobbying for more
WASHINGTON — Sellers of health savings accounts see an opening for expanding their market, and they’re ramping up lobbying efforts to seize the opportunity. A group...
-
Uncategorized6 months agoCommon Ancestry Limits Protein Sequence Exploration, Computational Study Shows
For all the excitement surrounding AlphaFold and the surge of AI‑driven protein design tools, one fact often goes unexamined: nearly every model is trained on databases...
-
Uncategorized6 months ago
Scalable single-cell total RNA sequencing unifies coding and noncoding transcriptomics
Nature Biotechnology, Published online: 31 March 2026; doi:10.1038/s41587-026-03068-6 Simultaneous profiling of adenylated and non-adenylated RNAs reveals regulatory programs across diverse cell types.
-
Uncategorized6 months agoSTAT+: Pharma giant Takeda to lay off nearly 250 workers in latest job cutting
Takeda Pharmaceuticals will lay off nearly 250 workers in Cambridge, the state’s largest biopharma employer announced through a state filing. The layoffs will begin in July, although some...
FDA warning letter accuses Bausch & Lomb of lacking commitment to remediation
Deep dive: Psychedelics back on FDA’s doorstep
‘Patients are not a renewable resource’: Rethinking rare disease R&D
Scientists turn pig semen extract into eye drops that kill cancer in mice
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
